Species Distribution and Comparison between EUCAST and Gradient Concentration Strips Methods for Antifungal Susceptibility Testing of 112 Aspergillus Section Nigri Isolates
暂无分享,去创建一个
S. Ranque | P. Le Pape | R. Piarroux | L. Lachaud | N. Zahr | F. Morio | A. Normand | D. Maubon | A. Fekkar | S. Imbert | M. Sasso | B. Carrara | R. Richards
[1] T. Toyotome,et al. Prospective survey of Aspergillus species isolated from clinical specimens and their antifungal susceptibility: A five-year single-center study in Japan. , 2020, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[2] R. Piarroux,et al. Multi-centric evaluation of the online MSI platform for the identification of cryptic and rare species of Aspergillus by MALDI-TOF. , 2019, Medical mycology.
[3] L. Trovato,et al. Environmental Isolates of Multi-Azole-Resistant Aspergillus spp. in Southern Italy , 2018, Journal of fungi.
[4] C. Deluca,et al. Method-Dependent Epidemiological Cutoff Values for Detection of Triazole Resistance in Candida and Aspergillus Species for the Sensititre YeastOne Colorimetric Broth and Etest Agar Diffusion Methods , 2018, Antimicrobial Agents and Chemotherapy.
[5] Hsuan‐Chen Wang,et al. Comparison of the Sensititre YeastOne and CLSI M38-A2 Microdilution Methods in Determining the Activity of Amphotericin B, Itraconazole, Voriconazole, and Posaconazole against Aspergillus Species , 2018, Journal of Clinical Microbiology.
[6] M. Faria,et al. Aspergillus Species and Antifungals Susceptibility in Clinical Setting in the North of Portugal: Cryptic Species and Emerging Azoles Resistance in A. fumigatus , 2018, Front. Microbiol..
[7] Y. Le Govic,et al. Successful treatment of a recurrent Aspergillus niger otomycosis with local application of voriconazole. , 2018, Journal de mycologie medicale.
[8] R. Arenas,et al. Identification of Aspergillus tubingensis in a primary skin infection. , 2018, Journal de mycologie medicale.
[9] S. Rezaie,et al. Species identification and in vitro antifungal susceptibility testing of Aspergillus section Nigri strains isolated from otomycosis patients. , 2018, Journal de mycologie medicale.
[10] R. Herbrecht,et al. Isavuconazole: A new broad-spectrum azole. Part 1: In vitro activity. , 2018, Journal de mycologie medicale.
[11] R. Piarroux,et al. Black aspergilli: A remaining challenge in fungal taxonomy? , 2017, Medical mycology.
[12] J. Frisvad,et al. Aspergillus labruscus sp. nov., a new species of Aspergillus section Nigri discovered in Brazil , 2017, Scientific Reports.
[13] D. Hagiwara,et al. Drug Sensitivity and Resistance Mechanism in Aspergillus Section Nigri Strains from Japan , 2017, Antimicrobial Agents and Chemotherapy.
[14] J. Turnidge,et al. Multicenter Study of Method-Dependent Epidemiological Cutoff Values for Detection of Resistance in Candida spp. and Aspergillus spp. to Amphotericin B and Echinocandins for the Etest Agar Diffusion Method , 2016, Antimicrobial Agents and Chemotherapy.
[15] G. Goldman,et al. Epidemiological and Genomic Landscape of Azole Resistance Mechanisms in Aspergillus Fungi , 2016, Front. Microbiol..
[16] G. Crescenzo,et al. Species Distribution and In Vitro Azole Susceptibility of Aspergillus Section Nigri Isolates from Clinical and Environmental Settings , 2016, Journal of Clinical Microbiology.
[17] S. Ranque,et al. Aspergillus tubingensis: a major filamentous fungus found in the airways of patients with lung disease. , 2016, Medical mycology.
[18] B. Alexander,et al. Comparing Etest and Broth Microdilution for Antifungal Susceptibility Testing of the Most-Relevant Pathogenic Molds , 2015, Journal of Clinical Microbiology.
[19] Wei Liu,et al. Identification and Susceptibility of Aspergillus Section Nigri in China: Prevalence of Species and Paradoxical Growth in Response to Echinocandins , 2014, Journal of Clinical Microbiology.
[20] L. Dupont,et al. Invasive Aspergillus niger complex infections in a Belgian tertiary care hospital. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[21] M. Arendrup,et al. EUCAST technical note on Aspergillus and amphotericin B, itraconazole, and posaconazole. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[22] D. Denning,et al. Cryptic Species and Azole Resistance in the Aspergillus niger Complex , 2011, Antimicrobial Agents and Chemotherapy.
[23] E. Mellado,et al. Species Identification and Antifungal Susceptibility Patterns of Species Belonging to Aspergillus Section Nigri , 2009, Antimicrobial Agents and Chemotherapy.
[24] J. Meis,et al. Effect of pH on the In Vitro Activities of Amphotericin B, Itraconazole, and Flucytosine against Aspergillus Isolates , 2004, Antimicrobial Agents and Chemotherapy.